Supplemental Material for Efficacy of tranexamic acid in traumatic brain injury: Updated systematic review and meta-analysis by Mohamed Magdy Alhelaly, Ahmed Magdy Soliman, Anas Khaled, Hamed Ellotf, Mahmoud Mohamed Attia and Ahmed Elmaraezy in Trauma</p
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...
Development and application of statistical models for medical scientific researchAnalysis and suppor...
ObjectiveThe antifibrinolytic agent tranexamic acid (TXA) has demonstrated clinical benefit in traum...
Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people eac...
BackgroundAnti-fibrinolytic medications decrease traumatic intracranial haemorrhage (ICH). Tranexami...
In this issue of JAMA, Rowell and colleagues from the Resuscitation Outcomes Consortium report findi...
Introduction. The most important result of head trauma, which can develop with a blunt or penetratin...
Background and Objectives:. This systematic review and meta-analysis of randomized controlled trials...
BackgroundPrehospital tranexamic acid (TXA) may hold substantial benefits for trauma patients; howev...
Purpose: Traumatic brain injury (TBI) is a leading cause of death and disability. Intracranial hemor...
BACKGROUND: Traumatic brain injury (TBI) is a leading cause of death and disability. In many cases o...
BACKGROUND: Traumatic brain injury (TBI) is a leading cause of death and disability. In many cases o...
Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people eac...
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...
Development and application of statistical models for medical scientific researchAnalysis and suppor...
ObjectiveThe antifibrinolytic agent tranexamic acid (TXA) has demonstrated clinical benefit in traum...
Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people eac...
BackgroundAnti-fibrinolytic medications decrease traumatic intracranial haemorrhage (ICH). Tranexami...
In this issue of JAMA, Rowell and colleagues from the Resuscitation Outcomes Consortium report findi...
Introduction. The most important result of head trauma, which can develop with a blunt or penetratin...
Background and Objectives:. This systematic review and meta-analysis of randomized controlled trials...
BackgroundPrehospital tranexamic acid (TXA) may hold substantial benefits for trauma patients; howev...
Purpose: Traumatic brain injury (TBI) is a leading cause of death and disability. Intracranial hemor...
BACKGROUND: Traumatic brain injury (TBI) is a leading cause of death and disability. In many cases o...
BACKGROUND: Traumatic brain injury (TBI) is a leading cause of death and disability. In many cases o...
Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people eac...
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...
International audienceNon-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage...